Comparison · updated October 28, 2026

Embody vs Hers: Embody for a simple cash-pay injection plan, Hers for a women-focused care platform

We would start with Embody for a low-entry-cost compounded injection, if your clinician considers it appropriate.

These two prices are different kinds of bill, so read the line under each price before you compare them.

Both providers pay us a commission through our links. Commissions do not set scores or the facts compared here. How we make money

Who each one suits

We would start with Embody for a low-entry-cost compounded injection, if your clinician considers it appropriate. Its public one-month semaglutide plan is $79 with medication included. Choose Hers if you want a women-focused platform with FDA-approved pill and injection options, care-team support and app tracking. Hers charges membership separately from medication. Both can be useful services; our recommendation turns on whether you want a simple injection bundle or the broader treatment choices at Hers.

Sources: Embody catalogue and payment terms · Hers program and care details

By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

Embody vs Hers side by side

Embody and Hers compared fact by fact
EmbodyHers
Pricefrom $49/mo$188First month, then $298/mo
MedicineCompounded onlyBrand-name only
Needle-free optionNot listedYes, a pill or other oral form
InsuranceBothNo insurance listed
ConsultationIncludedIncluded in required Weight Loss Membership ($39 first month, then $149/mo)
ShippingFreeHers advertises free delivery; confirm delivery terms if a separate pharmacy fulfils your prescription
Where it ships49 states plus DC, all except LouisianaNot confirmed
Trustpilot3.8 / 5 across 10,100 reviews3.3 / 5 across 10,563 reviews
BBB ratingD+ (not accredited)Accredited (since 2018, profile: Hims & Hers Inc., San Francisco CA)
Our score7.6/10 Good4.7/10 Limited
Assessment limitsChecked Oct 16, 2026; a rating claim didn't match Trustpilot.Checked Oct 16, 2026; some details not published.

What Embody and Hers plans cost

Embody

Four published plan lengths for each injection. A sale advertised October 27 through December 1, 2026 cut the twelve-month prepaid amounts to $588 for semaglutide and $1,188 for tirzepatide; one-month plans stayed at $79 and $129.

All 8 Embody plans

Payments are normally non-refundable; a limited medical-disqualification exception applies.

How Embody bills

The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.

We checked Embody's prices on October 27, 2026.Every Embody price and plan

Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.

Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.

Hers

A women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and listed Zepbound access (medication from $299, with required membership billed separately).

All 10 Hers plans
How Hers bills

Combined medication and membership cost for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies

We checked Hers' prices on August 14, 2026.

When would we choose Hers over Embody?

Hers is a useful alternative when you want to discuss an approved pill or injection through a women-focused platform. Its membership includes care-team access, weight tracking and dose-management support. Add the required membership to the prescribed medication price: the membership is $39 in month one and $149 per month afterward. Our Hers pricing record separates those charges.

Sources:Hers program and care details

What should you check before choosing Embody?

Embody's public catalogue lets you compare one month with longer prepaid terms. The semaglutide options on October 27 were $79 for one month or $588 paid for twelve months, equivalent to $49 a month, in a yearly-plan sale advertised through December 1, 2026. The lower equivalent was a commitment, not a $49 monthly bill. Confirm any current twelve-month price, the renewal amount and its date during signup.

For an eligible patient who wants a compounded injection, that one-month option is our practical starting point. Clinical approval is required. Compounded medicines are not FDA approved, and paid plans are normally non-refundable; Embody publishes a limited exception for provider-determined medical disqualification. Compare the plan's fit before committing to a longer term.

Sources:Embody catalogue and payment terms· Embody cancellation and refund terms· FDA on compounded medicines

What to watch for with Embody and Hers

Embody

  • Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. During the sale advertised through December 1, 2026, the twelve-month semaglutide plan committed $588 up front; cancellation requests must reach support at least 72 hours before the next billing date.
  • The $49/$99 sale rates, advertised through December 1, 2026, required twelve-month prepayment of $588/$1,188 rather than monthly payments. Confirm any current price, the renewal amount and its date for your selected plan before paying.
Embody's strengths, cautions and terms

Strengths

  • The October 27, 2026 catalogue published four price tiers for each molecule: semaglutide $79/$76/$73/$49 and tirzepatide $129/$126/$123/$99 across one, three, six and twelve months. The twelve-month prices were a sale advertised through December 1, 2026, paid up front.
  • One-month injection prices of $79 for semaglutide and $129 for GLP-1 + GIP were visible in Embody's catalogue on September 20, 2026. The FAQ says the selected rate holds within the chosen plan.
  • Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
  • Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and limited medical-disqualification refund exception are readable before you pay.
  • Publishes responses to customer reviews on Trustpilot, giving readers the company's reply alongside individual complaints.

More to watch for

  • Trustpilot showed 3.8 / 5 across 10,100 reviews on October 17, 2026, while the landing page advertised 4.8 on our prior check. The Trustpilot profile includes merged reviews from another profile, and individual reports cover different pricing periods. It is not a measure of clinical quality.
  • Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
  • Embody's public catalogue lists only compounded injections; it doesn't list branded Wegovy, Zepbound, Mounjaro or Ozempic.
  • Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others. Embody's October 27 catalogue listed a yearly-plan sale, advertised through December 1, 2026, with $49 semaglutide and $99 tirzepatide monthly equivalents; SnagRx has its own prices and payment terms. Read our SnagRx review, then compare Embody and SnagRx side by side.
Medicines listed
  • Compounded semaglutide (injectable)
  • Compounded tirzepatide (injectable)
Insurance
No insurance support listed
Consultation
Included
Shipping
Free
Prescribers
OpenLoop Health clinical network (individual credentials MD/NP/PA not publicly listed before signup)
Lab work
Not disclosed
States
49 states plus DC, all except Louisiana. In Nebraska, service is limited to patients 19 and older (verified 2026-09-03)
Cancellation
Choose a monthly, 3-, 6- or 12-month plan at signup. Cancellation requests must reach support at least 72 hours before the next billing date, and the policy dated August 25, 2026 says all payments are final and non-refundable, with a refund for unused services on provider-determined medical disqualification, after deductions for services already provided. Multi-month plans are non-refundable in whole and in part.

Hers

  • Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
  • Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can raise the total above $188 and $298
Hers' strengths, cautions and terms

Strengths

  • Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
  • Hers lists brand-name Zepbound access, with medication billed separately from the required Weight Loss Membership
  • Part of publicly traded Hims & Hers Health, Inc. (NYSE: HIMS)
  • Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

More to watch for

  • Care is delivered online through messaging and the app; confirm how to reach the care team for prescription or refill questions
  • Older compounded-plan prices do not establish the current product, dose or full bill; confirm the actual prescription and checkout
  • Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Medicines listed
  • Wegovy (brand-name injection pen)
  • Wegovy (brand-name oral pill)
  • Ozempic (brand-name injection pen, FDA approved for type 2 diabetes and prescribed off label for weight loss)
  • Ozempic (brand-name oral pill, FDA approved for type 2 diabetes and prescribed off label for weight loss)
  • Foundayo (brand-name oral pill)
  • Zepbound (brand-name)
Insurance
No insurance support listed
Consultation
Included in required Weight Loss Membership ($39 first month, then $149/mo)
Shipping
Hers advertises free delivery; confirm delivery terms if a separate pharmacy fulfils your prescription
States
Not confirmed. Hers says its GLP-1 offering does not cover every state, but its medication FAQ does not name the excluded states. Confirm your state and prescribed treatment before enrolling (checked 2026-09-26)
Cancellation
Hers' [weight-loss terms](https://www.forhers.com/terms-and-conditions) require cancellation at least two days before the originally scheduled billing date. Use My Subscriptions in your account or its Customer Help Center. Canceling medication alone leaves membership active; canceling membership also ends its medication plan. After a prepaid supply ships, membership charges can continue until that supply period ends. The first membership month and shipped medication are nonrefundable. Gifthealth-billed medication has separate cancellation and refund rules.

Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.

Where these facts come from

Embody:prices checked October 27, 2026, score evidence assessed October 16, 2026.Read our Embody review

Hers:prices checked August 14, 2026, score evidence assessed October 16, 2026.Read our Hers review

We score on a published methodology, and partnership never changes a score or a fact here.

What should you compare next?